DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
An independent panel of scientists from the National Academy of Sciences (NAS) has affirmed the National Toxicology Program’s 2011 classification of formaldehyde as a “known human carcinogen” in its 12th Report of Carcinogens (RoC). Read more about the NAS panel's findings on formaldehyde carcinogenicity.
In August, DCEG scientists participated in the 29th International Papillomavirus Conference in Seattle, Washington. The meeting highlighted basic, clinical, and public health science topics ranging from molecular virology to novel cancer screening and treatment strategies to global public health.
Aimée R. Kreimer, Ph.D., presented a plenary talk on “Oral HPV natural history and its progression to oropharyngeal cancer.” View a list of other DCEG speakers and participants at the conference.
In July, Christian C. Abnet, Ph.D., M.P.H., was named Acting Chief of the Nutritional Epidemiology Branch (NEB). Dr. Abnet joined NCI as a Cancer Prevention Fellow in 1998, became a tenure-track investigator in NEB in 2005, and was awarded tenure in May 2014.
Over the past 14 years, researchers in the Clinical Genetics Branch (CGB), led by Branch Chief Sharon Savage, M.D., have carried out a study of dyskeratosis congenita (DC) at the NIH Clinical Center to better understand the disorder and to identify the genes responsible for it.
Using exome sequencing, Dr. Savage and her team have identified several genes that cause DC, including RTEL1, a gene known to be involved in telomere biology. Discovery of a rare founder mutation in this gene has led to a direct benefit for at least one DC family. Read more about this discovery.
In June, Yikyung Park, Sc.D., left the Nutritional Epidemiology Branch (NEB) to take a position as an associate professor in the Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, Missouri.
Dr. Park joined DCEG in 2006 as an NIH-AARP postdoctoral fellow and was later promoted to a staff scientist. She managed the Division’s activities within the NIH-AARP Diet and Health Study and supervised the linking of AARP and Medicare data. Dr. Park's leadership in this effort has provided a unique opportunity to create a longitudinal dataset that includes both pre- and post-diagnostic diet and lifestyle information, as well as cancer treatment and comorbidity data. This valuable dataset will strengthen ongoing research of medically-documented conditions related to cancer incidence, survival, and non-cancer outcomes.
In June, Stephen J. Chanock, M.D., DCEG Director, and Lindsay Morton, Ph.D., delivered talks at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. Dr. Chanock chaired a session on “Cancer genomics and inherited risk: Recent advances and current challenges,” in which he spoke on “Next-generation sequencing: Basic principles and interplay of tumor and germ-line genomes.” Dr. Morton chaired a session on “Second cancer: Genomics and detection,” in which she presented on “The rising tide of second cancers: 16% and climbing.”
In May, Christian C. Abnet, Ph.D., M.P.H., was awarded scientific tenure by the NIH. Dr. Abnet earned a Ph.D. in environmental toxicology from the University of Wisconsin in 1998 and an M.P.H. in epidemiology from the University of Minnesota in 1999. Since joining DCEG’s Nutritional Epidemiology Branch as a tenure-track investigator in 2005, Dr. Abnet has focused his work on the etiology of esophageal and gastric cancer and the lifestyle, environmental, and genetic contributions to the development of these diseases. He also studies the microbiome and its associations with cancer. Read more about Dr. Abnet.
In May, investigators from the Radiation Epidemiology Branch participated in the 2014 Gilbert W. Beebe Symposium, hosted by The National Academy of Sciences and NCI. This year’s symposium, titled The Science and Response to a Nuclear Reactor Accident, focused on current scientific knowledge and response plans for a nuclear reactor accident. Read more about the Beebe Symposium.
Shelia H. Zahm, Sc.D., and Dalsu A.N. Baris, M.D., Ph.D., received an Honorable Mention Alice Hamilton Award in the category of Epidemiology and Surveillance from the National Institute for Occupational Safety and Health (NIOSH). These awards recognize the scientific excellence of technical and instructional materials by scientists and engineers in the areas of biological science, engineering and physical science, human studies, and educational materials. Drs. Zahm and Baris were honored for their work on the firefighters study led by NIOSH, which included updated follow-up of the NCI Philadelphia Firefighters Study.
On May 6, cancer researchers from across the country and around the globe gathered with colleagues from NIH for a scientific symposium to celebrate 50 years of visionary leadership by Joseph F. Fraumeni, Jr., M.D., founding Director of DCEG. Nearly 350 scientists attended the symposium, titled “Cancer Epidemiology: From Pedigrees to Populations,” which focused on a selection of some of the major scientific themes that flourished and expanded out of Dr. Fraumeni’s groundbreaking research into cancer etiology and prevention. Read more about this special event.
In May, Robert N. Hoover, M.D., Sc.D., Director of the Epidemiology and Biostatistics Program, presented the 159th Cutter Lecture on Preventive Medicine at the Harvard School of Public Health. His lecture was titled “Hormonal carcinogenesis across the life course.” Since 1912, this has been one of the most respected institutionalized lectures in the fields of preventive medicine and epidemiology. Lecturers have included some of the most distinguished public health scientists, researchers, and professionals, including the founders of modern epidemiology.
In April, several DCEG staff members took part in the annual meeting of the American Association for Cancer Research (AACR) in San Diego, California. This five-day event highlighted the latest scientific advances in basic, clinical, and epidemiologic cancer research. The theme of this year’s meeting was Harnessing Breakthroughs – Targeting Cures. Read more about the 2014 AACR meeting.